# Brain Network Dynamics of Depression During Esketamine Treatment

> **NCT06012916** · — · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 8 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Esketamine nasal spray

## Key facts

- **NCT ID:** NCT06012916
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-03
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-08-30
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06012916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06012916, "Brain Network Dynamics of Depression During Esketamine Treatment". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06012916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*